JP2002155035A - 3-amino-1-indanol, method for synthesizing the same and optical isomer separating agent comprising the same - Google Patents

3-amino-1-indanol, method for synthesizing the same and optical isomer separating agent comprising the same

Info

Publication number
JP2002155035A
JP2002155035A JP2001268690A JP2001268690A JP2002155035A JP 2002155035 A JP2002155035 A JP 2002155035A JP 2001268690 A JP2001268690 A JP 2001268690A JP 2001268690 A JP2001268690 A JP 2001268690A JP 2002155035 A JP2002155035 A JP 2002155035A
Authority
JP
Japan
Prior art keywords
indanol
amino
optically active
formula
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2001268690A
Other languages
Japanese (ja)
Inventor
Kazuhiko Saigo
和彦 西郷
Kazu Kanehara
数 金原
Yoshiyuki Katsumata
義之 勝俣
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to JP2001268690A priority Critical patent/JP2002155035A/en
Publication of JP2002155035A publication Critical patent/JP2002155035A/en
Pending legal-status Critical Current

Links

Landscapes

  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

PROBLEM TO BE SOLVED: To provide a compound which is expected to be a synthetic intermediate for medicines and agrochemicals, a separating agent for chromatography, or an optically resolving agent for racemates. SOLUTION: This 3-amino-1-indanol represented by formula (I) (OH and NH2 are arranged in the cis-or trans-configuration, and the 3-amino-1-indanol may be a racemate or an optically active isomer), a method for synthesizing the same, an optically active isomer of the 3-amino-1-indanol, and a method for optically resolving the 3-amino-1-indanol, and an optical isomer separating agent containing the optically active isomer as an active ingredient.

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【発明の属する技術分野】本発明は新規物質である3−
アミノ−1−インダノール及びその合成法、更には3−
アミノ−1−インダノールの光学活性体、及びその光学
分割方法、並びにこの光学活性体を有効成分とする光学
異性体用分離剤に関するものである。
TECHNICAL FIELD The present invention relates to a novel substance 3-
Amino-1-indanol and its synthesis method, and 3-
The present invention relates to an optically active form of amino-1-indanol, an optical resolution method thereof, and an optical isomer separating agent containing the optically active form as an active ingredient.

【0002】[0002]

【従来の技術及び発明が解決しようとする課題】アミノ
インダノールは、医・農薬等の生理活性物質を始めとす
る、種々のファインケミカル誘導体の重要な中間体であ
る。例えば、シス−1−アミノ−2−インダノールは、
J.Med.Chem.,35,2525(1992)、J.Med.Chem.,35,1702(199
2)、J..Med.Chem,35,1685(1992)等に、抗HMV薬製造
の有効中間体であることが開示されている。
2. Description of the Related Art Aminoindanol is an important intermediate of various fine chemical derivatives including physiologically active substances such as medical and agricultural chemicals. For example, cis-1-amino-2-indanol is
J. Med. Chem., 35, 2525 (1992), J. Med. Chem., 35, 1702 (1992)
2), J. Med. Chem, 35, 1685 (1992) and the like disclose that it is an effective intermediate for the production of anti-HVM drugs.

【0003】また、光学活性なアミノインダノール類
は、光学活性カルボン酸(キラル酸)の分離剤として有
効であり、例えば特表平11−511742号公報には
1−アミノインダン−2−オールによるキラル酸分離プ
ロセスが開示されている。
[0003] Optically active aminoindanols are effective as a separating agent for optically active carboxylic acids (chiral acids). For example, Japanese Patent Publication No. 11-511742 discloses 1-aminoindan-2-ol. A chiral acid separation process is disclosed.

【0004】3−アミノ−1−インダノールも、医・農
薬の合成中間体、またはクロマト分離剤やラセミ体の光
学分割剤等として期待される化合物であるが、その合成
に成功した例はなく、合成方法の確立が強く望まれてい
た。
[0004] 3-Amino-1-indanol is also a compound expected as an intermediate for synthesis of medical and agricultural chemicals, or as a chromatographic separating agent or a racemic optical resolving agent, but there has been no example of successful synthesis. The establishment of a synthesis method has been strongly desired.

【0005】[0005]

【課題を解決するための手段】本発明者らは前記課題を
解決するべく鋭意研究した結果、新規物質である3−ア
ミノ−1−インダノール、及び入手容易な原料を用いた
安易な3−アミノ−1−インダノールの合成方法、更に
は得られた3−アミノ−1−インダノールの有効な光学
分割方法、並びにこの3−アミノ−1−インダノールの
光学活性体を有効成分とする光学異性体用分離剤を見出
し、本発明を完成させるに至った。
The present inventors have conducted intensive studies to solve the above-mentioned problems, and as a result, have found that 3-amino-1-indanol which is a novel substance, and 3-amino-1-indanol which is easily available using raw materials. Method for synthesizing -1-indanol, effective method for resolving the obtained 3-amino-1-indanol, and separation for optical isomers using the optically active form of 3-amino-1-indanol as an active ingredient An agent was found, and the present invention was completed.

【0006】即ち、本発明は、式(I)で表される3−
アミノ−1−インダノールを提供する。
That is, the present invention provides a compound represented by the formula (I):
Provide amino-1-indanol.

【0007】[0007]

【化5】 Embedded image

【0008】(式中、OH基とNH2基はシス配置また
はトランス配置であり、ラセミ体でも光学活性体でもよ
い。) また、本発明は、式(II)
(In the formula, the OH group and the NH 2 group have a cis configuration or a trans configuration, and may be a racemate or an optically active compound.) The present invention provides a compound represented by the formula (II)

【0009】[0009]

【化6】 Embedded image

【0010】で表されるβ−フェニル−β−アラニンの
アミノ基を保護基で保護して、式(III)
The amino group of β-phenyl-β-alanine represented by the formula (III)

【0011】[0011]

【化7】 Embedded image

【0012】[式中、AはRCO−又はROCO−基を
示す。ここでRは炭素数1〜30のアルキル基又はアリ
ール基である。]で表される化合物を得、この化合物を
Friedel-Craftsアシル化することにより式(IV)
[In the formula, A represents an RCO- or ROCO- group. Here, R is an alkyl group or an aryl group having 1 to 30 carbon atoms. And a compound represented by the formula
Formula (IV) is obtained by Friedel-Crafts acylation.

【0013】[0013]

【化8】 Embedded image

【0014】(式中、Aは前記と同じ意味を示す。)で
表される化合物を得、更にこの化合物の保護基の除去及
び還元を行うことを特徴とする、上記式(I)で表され
る3−アミノ−1−インダノールの合成方法、更には3
−アミノ−1−インダノールの光学活性体、及び上記式
(I)で表される3−アミノ−1−インダノールの光学
活性体混合物を光学活性カルボン酸と作用させた後、生
成するジアステレオマー塩を分離することを特徴とする
3−アミノ−1−インダノールの光学分割方法、並びに
上記式(I)で表される3−アミノ−1−インダノール
の光学活性体を有効成分とする光学異性体用分離剤を提
供する。
(Wherein A has the same meaning as described above), and the protecting group of this compound is removed and reduced. Method for synthesizing 3-amino-1-indanol,
A diastereomer salt formed after reacting a mixture of an optically active form of -amino-1-indanol and an optically active form of 3-amino-1-indanol represented by the above formula (I) with an optically active carboxylic acid For isolating 3-amino-1-indanol, and an optical isomer containing an optically active form of 3-amino-1-indanol represented by the above formula (I) as an active ingredient. Provide a separating agent.

【0015】[0015]

【発明の実施の形態】本発明の式(I)で表される3−
アミノ−1−インダノールは、シス体又はトランス体、
あるいは、ラセミ体又は光学活性体であってもよい。
BEST MODE FOR CARRYING OUT THE INVENTION
Amino-1-indanol is a cis or trans form,
Alternatively, it may be racemic or optically active.

【0016】出発原料となるβ−フェニル−β−アラニ
ン(II)は、ベンズアルデヒドとマロン酸と酢酸アンモ
ニウムから公知の方法で合成することができる。得られ
たβ−フェニル−β−アラニン(II)は、無水酢酸、塩化
ベンゾイル、9−フルオレニルメチルクロロホルメー
ト、塩化ベンジルオキシカルボニル、ジt−ブチルジカ
ルボネート等の、アミノ基の保護基となりうる基を有す
る化合物を用いて、そのアミノ基を保護基で保護して化
合物(III)を得る。アミノ基の保護基としては、アセ
チル基、ベンゾイル基が好ましく、アセチル基が更に好
ましい。次いで化合物(III)のFriedel-Craftsアシル
化反応を行うことで、式(IV)で表されるインダン骨格
を持つ化合物を得ることができる。Friedel-Craftsアシ
ル化は、例えば、まず、化合物(III)にPCl5 を添
加し、エチルエーテル、THF等の溶媒中で反応させた
後、更に、塩化メチレン等の溶媒中で、0〜5℃の温度
でAlCl3 を加えて反応させることにより行う。ここ
までの反応の概要を以下の反応式に示す。
Β-phenyl-β-alanine (II) as a starting material can be synthesized from benzaldehyde, malonic acid and ammonium acetate by a known method. The obtained β-phenyl-β-alanine (II) is a protecting group for an amino group such as acetic anhydride, benzoyl chloride, 9-fluorenylmethyl chloroformate, benzyloxycarbonyl chloride, and di-t-butyl dicarbonate. Using a compound having a group that can be used, the amino group is protected with a protecting group to obtain a compound (III). As the amino-protecting group, an acetyl group and a benzoyl group are preferable, and an acetyl group is more preferable. Next, a compound having an indane skeleton represented by the formula (IV) can be obtained by performing a Friedel-Crafts acylation reaction of the compound (III). The Friedel-Crafts acylation is carried out, for example, by first adding PCl 5 to the compound (III) and reacting it in a solvent such as ethyl ether or THF, and then further in a solvent such as methylene chloride at 0 to 5 ° C. The reaction is carried out by adding AlCl 3 at a temperature of. The outline of the reaction so far is shown in the following reaction formula.

【0017】[0017]

【化9】 Embedded image

【0018】(式中、Aは前記と同じ意味を示し、Ac
はアセチル基、Phはフェニル基を示す。) 続いて得られた化合物(IV)の保護基の除去及び還元を
行うことで、3−アミノ−1−インダノールを得ること
ができるが、化合物(IV)の保護基の除去及び還元の方
法により、トランス体とシス体の割合を変化させること
ができ、トランス体及びシス体を選択的に合成すること
ができる。以下、トランス体及びシス体の合成法につい
て詳述する。
(Wherein A has the same meaning as described above;
Represents an acetyl group, and Ph represents a phenyl group. Subsequently, by removing and reducing the protecting group of the obtained compound (IV), 3-amino-1-indanol can be obtained. However, the method of removing and reducing the protecting group of compound (IV) can be used. The ratio of the trans form and the cis form can be changed, and the trans form and the cis form can be selectively synthesized. Hereinafter, the method for synthesizing the trans and cis isomers will be described in detail.

【0019】まず、化合物(IV)からの(±)−トラン
ス−3−アミノ−1−インダノール(ラセミ体)(I−
1)の合成方法の概要を下記に示す。
First, (±) -trans-3-amino-1-indanol (racemic) (I-
The outline of the synthesis method 1) is shown below.

【0020】[0020]

【化10】 Embedded image

【0021】(式中、Aは前記と同じ意味を示す。) 即ち、上記で得られた化合物(IV)を、酸性条件下、加
熱還流を行い、保護基を除去して塩酸塩(V)を得、更
に、カルボニル基の還元を行うことにより、式(I)で
表される3−アミノ−1−インダノールをトランス:シ
ス=3:1の割合でトランス体を優先的に入手すること
ができる。カルボニル基から水酸基への還元は、例えば
水素化ホウ素ナトリウム等の金属ヒドリド試薬を用いる
ことにより行うことができる。
(In the formula, A has the same meaning as described above.) That is, the compound (IV) obtained above is heated under reflux under acidic conditions to remove the protecting group and remove the hydrochloride (V). And the carbonyl group is further reduced to obtain the 3-amino-1-indanol represented by the formula (I) preferentially in the trans form at a ratio of trans: cis = 3: 1. it can. The reduction from the carbonyl group to the hydroxyl group can be performed by using a metal hydride reagent such as sodium borohydride.

【0022】上記で得られたトランス体とシス体の混合
物(I)を精製することにより、(±)−トランス−3
−アミノ−1−インダノール(ラセミ体)(I−1)を
得ることができる。精製法としては、例えば、混合物
(I)と、2−ナフチル酢酸等の2−アリールカルボン
酸との塩を形成させ、これを塩化メチレン等の溶媒中で
加熱還流して室温放置する方法が好適に用いられる。こ
の方法により、トランス体の塩のみを選択的に結晶化さ
せることができる。続いて、炭酸水素ナトリウム、炭酸
水素カリウム、炭酸ナトリウム、炭酸カリウム、水酸化
ナトリウム及び水酸化カリウム等から選ばれるアルカリ
水溶液を作用させた後、適当な有機溶媒で抽出すること
により、上記トランス体(I−1)を得ることができ
る。
By purifying the mixture (I) of the trans-form and the cis-form obtained above, (±) -trans-3
-Amino-1-indanol (racemate) (I-1) can be obtained. As a purification method, for example, a method of forming a salt of the mixture (I) with a 2-arylcarboxylic acid such as 2-naphthylacetic acid, heating the mixture to reflux in a solvent such as methylene chloride, and leaving it at room temperature is preferable. Used for According to this method, only the trans-form salt can be selectively crystallized. Subsequently, an alkali aqueous solution selected from sodium hydrogencarbonate, potassium hydrogencarbonate, sodium carbonate, potassium carbonate, sodium hydroxide, potassium hydroxide, and the like is allowed to act thereon, followed by extraction with a suitable organic solvent, whereby the trans form ( I-1) can be obtained.

【0023】次に化合物(IV)からの(±)−シス−3
−アミノ−1−インダノール(ラセミ体)(I−2)の
合成方法の概要を下記に示す。
Next, (±) -cis-3 from compound (IV)
The outline of the method for synthesizing -amino-1-indanol (racemic) (I-2) is shown below.

【0024】[0024]

【化11】 Embedded image

【0025】(式中、Aは前記と同じ意味を示し、Ac
はアセチル基、Etはエチル基を示す。) 即ち、化合物(IV)を適当な有機溶媒に溶解し、例えば
水素化ホウ素を用いて還元反応を行うことにより、
(±)−N−アシル−3−アミノインダン−1−オール
(VI)をシス:トランス=3:1の割合でシス体を優先
的に入手することができる。この時の反応溶媒としては
テトラヒドロフラン(THF)が好ましい。また、反応
温度は−100〜−50℃が好ましい。次に、得られた
シス体とトランス体の混合物(VI)をクロマトグラフィ
ー、再結晶等で精製して、(±)−シス−N−アシル−
3−アミノインダン−1−オール(VII)を得る。
(Wherein, A has the same meaning as described above;
Represents an acetyl group, and Et represents an ethyl group. That is, by dissolving the compound (IV) in an appropriate organic solvent and performing a reduction reaction using, for example, borohydride,
The cis form of (±) -N-acyl-3-aminoindan-1-ol (VI) can be preferentially obtained in a ratio of cis: trans = 3: 1. The reaction solvent at this time is preferably tetrahydrofuran (THF). The reaction temperature is preferably from -100 to -50C. Next, the obtained mixture (VI) of the cis-form and the trans-form is purified by chromatography, recrystallization and the like to give (±) -cis-N-acyl-
3-aminoindan-1-ol (VII) is obtained.

【0026】得られた(±)−シス−N−アシル−3−
アミノインダン−1−オール(VII)を適当な塩基性有
機溶媒中で加熱還流後、適当な有機溶媒で抽出すること
により(±)−シス−3−アミノ−1−インダノール
(ラセミ体)(I−2)を得ることができる。この時の
塩基性有機溶媒としては、水酸化ナトリウム−エタノー
ル混合溶媒が好ましく、また、抽出溶媒としては塩化メ
チレンが好ましい。
The obtained (±) -cis-N-acyl-3-
The aminoindan-1-ol (VII) is heated under reflux in a suitable basic organic solvent and then extracted with a suitable organic solvent to give (±) -cis-3-amino-1-indanol (racemic) (I -2) can be obtained. At this time, the basic organic solvent is preferably a sodium hydroxide-ethanol mixed solvent, and the extraction solvent is preferably methylene chloride.

【0027】3−アミノ−1−インダノールのラセミ体
の光学分割は、光学活性カルボン酸を用いたジアステレ
オマー塩法で行うことができる。用いる光学活性カルボ
ン酸には特に制限はないが、ジベンゾイル酒石酸を用い
ると効率よく光学活性体を得ることができ好ましい。
The optical resolution of the racemic 3-amino-1-indanol can be carried out by a diastereomer salt method using an optically active carboxylic acid. The optically active carboxylic acid to be used is not particularly limited, but dibenzoyltartaric acid is preferably used because an optically active substance can be obtained efficiently.

【0028】光学分割時に使用する溶媒には特に制限は
ないが、水−エタノール混合溶媒が好ましい。晶析温度
は0〜60℃の範囲、好ましくは10〜40℃の範囲が
良い。必要であれば晶析したジアステレオマー塩を再結
晶して、さらに光学純度の高い結晶性ジアステレオマー
塩を得ることもできる。
The solvent used for optical resolution is not particularly limited, but a mixed solvent of water and ethanol is preferred. The crystallization temperature is in the range of 0 to 60C, preferably 10 to 40C. If necessary, the crystallized diastereomer salt can be recrystallized to obtain a crystalline diastereomer salt having higher optical purity.

【0029】上記のようにして得られる3−アミノ−1
−インダノールの光学活性体は、光学異性体用分離剤、
特に、光学活性カルボン酸のラセミ体の光学分割剤とし
て有用である。
3-amino-1 obtained as described above
-The optically active form of indanol is an optical isomer separating agent,
Particularly, it is useful as a racemic optical resolution agent of an optically active carboxylic acid.

【0030】3−アミノ−1−インダノールの光学活性
体を用いて、光学活性カルボン酸を光学分割するには、
3−アミノ−1−インダノールの光学活性体と、光学活
性カルボン酸のラセミ体とを適当な溶媒中で混合した
後、ジアステレオマー塩を析出させる方法により、光学
活性なカルボン酸を得ることができる。特に2位にアリ
ール基を有するカルボン酸を好ましく光学分割すること
ができる。
To optically resolve an optically active carboxylic acid using an optically active form of 3-amino-1-indanol,
An optically active carboxylic acid can be obtained by mixing an optically active form of 3-amino-1-indanol and a racemic optically active carboxylic acid in a suitable solvent, and then precipitating a diastereomer salt. it can. In particular, a carboxylic acid having an aryl group at the 2-position can be preferably optically resolved.

【0031】[0031]

【実施例】以下本発明を実施例を用いて具体的に説明す
る。尚、本発明はこれらの実施例により制限されるもの
ではない。
DESCRIPTION OF THE PREFERRED EMBODIMENTS The present invention will be specifically described below with reference to embodiments. Note that the present invention is not limited by these examples.

【0032】実施例1[トランス−3−アミノ−1−イ
ンダノールの合成] (1)(±)−β−フェニル−β−アラニン(II)の合
成 ベンズアルデヒド115g(1.08mol)、マロン
酸113g(1.08mol)、酢酸アンモニウム16
7g(2.16mol)を、エタノール270mLに加
え、加熱還流下5時間攪拌した。析出してきた白色結晶
を濾過し、濾液を水−エタノール混合溶媒(1:4、
2.5L)から再結晶を行い、白色結晶の標記化合物
(II)85.14gを得た(収率48%)。
Example 1 [Synthesis of trans-3-amino-1-indanol] (1) Synthesis of (±) -β-phenyl-β-alanine (II) 115 g (1.08 mol) of benzaldehyde, 113 g of malonic acid ( 1.08 mol), ammonium acetate 16
7 g (2.16 mol) was added to 270 mL of ethanol, and the mixture was stirred under heating and reflux for 5 hours. The precipitated white crystals were filtered, and the filtrate was mixed with a water-ethanol mixed solvent (1: 4,
Recrystallization from 2.5 L) gave 85.14 g of the title compound (II) as white crystals (yield 48%).

【0033】(2)(±)−(N−アセチル)−β−フ
ェニル−β−アラニン(III)の合成 (1)で得た化合物(II)50g(0.33mol)
を、NaOH 13.32g(0.32mol)を溶か
した水200mLに溶解させ、無水酢酸78g(0.7
7mol)を加え、室温で4時間攪拌した。析出した白
色結晶を濾過し、水で良く洗浄して真空加熱乾燥するこ
とにより、標記化合物(III)55.85gを得た(収
率89%)。
(2) Synthesis of (±)-(N-acetyl) -β-phenyl-β-alanine (III) 50 g (0.33 mol) of compound (II) obtained in (1)
Was dissolved in 200 mL of water in which 13.32 g (0.32 mol) of NaOH was dissolved, and 78 g of acetic anhydride (0.7 g) was dissolved.
7 mol), and the mixture was stirred at room temperature for 4 hours. The precipitated white crystals were filtered, washed well with water, and dried by heating under vacuum to obtain 55.85 g of the title compound (III) (89% yield).

【0034】(3)(±)−(N−アセチル)−3−ア
ミノインダン−1−オン(IV)の合成 真空加熱乾燥後、アルゴン置換したナスフラスコに、
(2)で得た化合物(III)55.00g(0.27m
ol)、PCl5 55.31g(0.27mol)を入
れ、これにエチルエーテル160mL、THF40mL
を加え、0℃で30分攪拌した後、室温で5時間攪拌し
た。続いて、溶媒を減圧留去し、エチルエーテル(3×
100mL)で洗浄し、再びエチルエーテルを減圧留去
した後、真空乾燥した。これに塩化メチレン300mL
を加え、0℃で攪拌しながら、AlCl3 177g
(1.35mol)をゆっくり加えた。さらに室温で
2.5時間攪拌した後、1Lの氷を入れた2L三角フラ
スコに反応液を注ぎ、AlCl3が完全に反応し終わっ
たのを確認後、塩化メチレン(4×400mL)で抽出
した。有機層を硫化ナトリウムで乾燥させ、乾燥剤を濾
別した後、溶媒を減圧留去して真空乾燥することによ
り、標記の粗生成物(IV)48.70gを得た。これを
シリカゲルカラムクロマトグラフィー(酢酸エチル)に
より、分離、精製し、さらに酢酸エチル(300mL)
から再結晶を行うことにより、標記化合物(IV)38.
24gを得た(収率76%)。
(3) Synthesis of (±)-(N-acetyl) -3-aminoindan-1-one (IV)
55.00 g (0.27 m) of the compound (III) obtained in (2)
ol) and 55.31 g (0.27 mol) of PCl 5 , and 160 mL of ethyl ether and 40 mL of THF were added thereto.
After stirring at 0 ° C. for 30 minutes, the mixture was stirred at room temperature for 5 hours. Subsequently, the solvent was distilled off under reduced pressure, and ethyl ether (3 ×
(100 mL), and ethyl ether was again distilled off under reduced pressure, followed by vacuum drying. 300 mL of methylene chloride
177 g of AlCl 3 while stirring at 0 ° C.
(1.35 mol) was added slowly. After further stirring at room temperature for 2.5 hours, the reaction solution was poured into a 2 L Erlenmeyer flask containing 1 L of ice, and after confirming that AlCl 3 was completely reacted, extraction was performed with methylene chloride (4 × 400 mL). . The organic layer was dried over sodium sulfide, the desiccant was removed by filtration, the solvent was distilled off under reduced pressure, and the residue was dried under vacuum to obtain 48.70 g of the title crude product (IV). This was separated and purified by silica gel column chromatography (ethyl acetate), and further ethyl acetate (300 mL)
From the title compound (IV).
24 g were obtained (76% yield).

【0035】融点 155〜158℃1 H−NMR(CDCl3) δ=2.055(s,3H), 2.468(d
d,1H,J=3.3,19.2), 3.216(dd,1H,J=7.8,19.2), 5.681(d
t,1H,J=3.3,7.8), 5.956(s,1H), 7.453-7.754(m,4H) (4)(±)−3−アミノインダン−1−オン塩酸塩
(V)の合成 (3)で得た化合物(IV)18.26g(0.097m
ol)を、1N 塩酸水溶液300mLに加え、加熱還
流下5時間攪拌した。反応が終了したことを確認後、溶
媒を減圧留去し真空乾燥することにより、標記化合物
(V)17.51gを得た。
Melting point 155-158 ° C. 1 H-NMR (CDCl 3 ) δ = 2.055 (s, 3H), 2.468 (d
d, 1H, J = 3.3,19.2), 3.216 (dd, 1H, J = 7.8,19.2), 5.681 (d
t, 1H, J = 3.3,7.8), 5.956 (s, 1H), 7.453-7.754 (m, 4H) (4) Synthesis of (±) -3-aminoindan-1-one hydrochloride (V) (3) 18.26 g (0.097 m) of the compound (IV) obtained in
ol) was added to 300 mL of a 1N aqueous hydrochloric acid solution, and the mixture was stirred under reflux with heating for 5 hours. After confirming that the reaction was completed, the solvent was distilled off under reduced pressure and dried under vacuum to obtain 17.51 g of the title compound (V).

【0036】融点 257℃1 H−NMR(D2O) δ=2.826-2.900(m,1H), 3.353
(dd,1H), 5.158-5.184(m,1H), 7.686-7.941(m,4H) IR(KBr) 3450, 3000, 2900, 1730, 1600, 1490,
1370, 1290, 1260, 780 cm-1 (5)(±)−トランス−3−アミノ−1−インダノー
ル(I−1)の合成 (4)で得た化合物(V)17.51gをエタノール4
50mLに溶解し、0℃に冷却してNaBH4 2.76
g(0.072mol)を徐々に加え、一晩攪拌した。
溶媒を大部分減圧留去し、水100mLを加え、塩化メ
チレン(5×200mL)で抽出した。有機層を硫酸ナ
トリウムで乾燥し、乾燥剤を濾別後、溶媒を減圧留去
し、真空乾燥することにより、(±)−3−アミノ−1
−インダノール(I)7.38gを得た。更に、水層を
減圧留去し真空乾燥後、エタノール200mLを加え、
0℃に冷却してNaBH4 1.22g(0.072mo
l)を加えた後、一晩攪拌した。続いて、溶媒を大部分
減圧留去し、水100mLを加え、塩化ナトリウムで乾
燥し、乾燥剤を濾別後、溶媒を減圧留去し、真空乾燥す
ることにより、(±)−3−アミノ−1−インダノール
(I)5.97gを得、合わせて13.35g(0.0
89mol)の(±)−3−アミノ−1−インダノール
(I)(トランス体:シス体=3:1の混合物)を得
た。これに、2−ナフチル酢酸17.5g(0.094
mol)を加え、クロロホルム1Lを加えて加熱還流
下、数分間攪拌した後、室温放置した。析出した白色塩
を濾別し、真空乾燥を行った。これに1N NaOH水
溶液100mLを加えて液性を塩基性にし、塩化メチレ
ン(5×300mL)で抽出した後、有機層を硫酸ナト
リウムで乾燥した。乾燥剤を濾別後、真空乾燥し、さら
にベンゼン−石油エーテル(5:1、300mL)から
再結晶を行うことにより、白色結晶の標記化合物(±)
−(I−1)7.02gを得た(2段階収率49%)。
257 ° C. 1 H-NMR (D 2 O) δ = 2.826-2.900 (m, 1H), 3.353
(dd, 1H), 5.158-5.184 (m, 1H), 7.686-7.941 (m, 4H) IR (KBr) 3450, 3000, 2900, 1730, 1600, 1490,
1370, 1290, 1260, 780 cm -1 (5) Synthesis of (±) -trans-3-amino-1-indanol (I-1) 17.51 g of the compound (V) obtained in (4) was dissolved in ethanol 4
Dissolve in 50 mL, cool to 0 ° C. and NaBH 4 2.76
g (0.072 mol) was gradually added, and the mixture was stirred overnight.
Most of the solvent was distilled off under reduced pressure, 100 mL of water was added, and the mixture was extracted with methylene chloride (5 × 200 mL). The organic layer was dried over sodium sulfate, the desiccant was filtered off, the solvent was distilled off under reduced pressure, and the residue was dried under vacuum to obtain (±) -3-amino-1.
7.38 g of indanol (I) were obtained. Further, the aqueous layer was distilled off under reduced pressure, and after vacuum drying, 200 mL of ethanol was added.
After cooling to 0 ° C., 1.22 g of NaBH 4 (0.072 mol
After l) was added, the mixture was stirred overnight. Subsequently, most of the solvent was distilled off under reduced pressure, 100 mL of water was added, and the mixture was dried over sodium chloride. After the desiccant was filtered off, the solvent was distilled off under reduced pressure, and the residue was dried under vacuum to obtain (±) -3-amino acid 5.97 g of 1-indanol (I) was obtained, and a total of 13.35 g (0.0
89 mol) of (±) -3-amino-1-indanol (I) (a mixture of trans-form: cis-form = 3: 1) was obtained. To this, 17.5 g of 2-naphthylacetic acid (0.094
mol), 1 L of chloroform was added, and the mixture was stirred under heating and reflux for several minutes, and then left at room temperature. The precipitated white salt was separated by filtration and vacuum-dried. The solution was made basic by adding 100 mL of a 1N aqueous solution of NaOH thereto, and extracted with methylene chloride (5 × 300 mL). The organic layer was dried over sodium sulfate. The desiccant was filtered off, dried in vacuo, and recrystallized from benzene-petroleum ether (5: 1, 300 mL) to give the title compound (±) as white crystals.
7.02 g of-(I-1) was obtained (49% in two steps).

【0037】融点 108〜110℃1 H−NMR(D2O) δ=1.583(br s,3H), 2.056(d
t,1H,J=6.3,13.7), 2.461(ddd,1H,J=3.0,6.3,13.7), 4.
641(t,1H,J=6.3), 5.336(dd,1H,J=3.0,6.3), 7.306-7.4
26(m,4H) IR(KBr)3350, 3300, 3125(br), 2925, 2700, 165
0, 1320, 1300, 1040,990, 780cm-1 (6)(±)−トランス−3−アミノ−1−インダノー
ル(I−1)の光学分割 (5)で得た化合物(±)−(I−1)7.52g
(0.05mol)、L−(+)−ジベンゾイル酒石酸
19.25g(0.051mol)を、水−エタノール
混合溶媒(1:1、630mL)に加熱溶解させ、室温
で放置した。析出した結晶を濾過し、さらに水−エタノ
ール混合溶媒(1:1、150mL)から再結晶を3回
行い、濾過、真空乾燥後、光学的に純粋な(1S,3
S)−トランス−3−アミノ−1−インダノール−L−
(+)−ジベンゾイル酒石酸塩(5.30g)を得た。
これに1N NaOH水溶液50mLを加えて液性を塩
基性にし、塩化メチレン(4×200mL)で抽出し
た。有機層を硫酸ナトリウムで乾燥後、乾燥剤を濾別
し、溶媒を減圧留去後、真空乾燥した。これをベンゼン
−ヘキサン(1:1、40mL)から再結晶することに
より、無色結晶の(1R,3R)−トランス−3−アミ
ノ−1−インダノール(I−1)1.10gを得た(収
率29%、光学純度99%e.e.以上)。
Melting point 108-110 ° C. 1 H-NMR (D 2 O) δ = 1.583 (brs, 3H), 2.056 (d
t, 1H, J = 6.3,13.7), 2.461 (ddd, 1H, J = 3.0,6.3,13.7), 4.
641 (t, 1H, J = 6.3), 5.336 (dd, 1H, J = 3.0,6.3), 7.306-7.4
26 (m, 4H) IR (KBr) 3350, 3300, 3125 (br), 2925, 2700, 165
0, 1320, 1300, 1040,990, 780 cm -1 (6) Optical resolution of (±) -trans-3-amino-1-indanol (I-1) Compound (±)-(I) obtained by (5) -1) 7.52 g
(0.05 mol) and 19.25 g (0.051 mol) of L-(+)-dibenzoyltartaric acid were dissolved by heating in a mixed solvent of water and ethanol (1: 1, 630 mL) and left at room temperature. The precipitated crystals were filtered, recrystallized three times from a mixed solvent of water and ethanol (1: 1, 150 mL), filtered, dried in vacuo, and optically pure (1S, 3).
S) -Trans-3-amino-1-indanol-L-
(+)-Dibenzoyl tartrate (5.30 g) was obtained.
The solution was made basic by adding 50 mL of a 1N aqueous NaOH solution, and extracted with methylene chloride (4 × 200 mL). After the organic layer was dried over sodium sulfate, the desiccant was filtered off, the solvent was distilled off under reduced pressure, and the residue was dried under vacuum. This was recrystallized from benzene-hexane (1: 1, 40 mL) to obtain 1.10 g of (1R, 3R) -trans-3-amino-1-indanol (I-1) as colorless crystals. Rate 29%, optical purity 99% ee or more).

【0038】融点 112〜113.5℃ [α]=39.3(c=1.00、エタノール) 一方、一回目の再結晶の濾液を減圧濃縮後、1N Na
OH水溶液50mLにより液性を塩基性にし、塩化メチ
レン(4×200mL)で抽出した。有機層を硫酸ナト
リウムで乾燥させ、乾燥剤を濾別後、溶媒を減圧留去
し、真空乾燥した。これに、D−(−)−ジベンゾイル
酒石酸7.20g(0.019mol)を加え、水−エ
タノール混合溶媒を用いて3回再結晶を行うことによ
り、光学的に純粋な(1R,3R)−トランス−3−ア
ミノ−1−インダノール−D−(−)−ジベンゾイル酒
石酸塩(3.15g)を得た。これに1N NaOH水
溶液50mLを加えて液性を塩基性にし、塩化メチレン
(4×200mL)で抽出した。有機層を硫酸ナトリウ
ムで乾燥後、乾燥剤を濾別し、溶媒を減圧留去後、真空
乾燥した。これをベンゼン−ヘキサン(1:1、40m
L)から再結晶することにより、無色結晶の(1S、3
S)−トランス−3−アミノ−1−インダノール(I−
1)1.43gを得た(収率38%、光学純度99%e.
e.以上)。
Melting point: 112 to 113.5 ° C. [α] = 39.3 (c = 1.00, ethanol) On the other hand, the filtrate of the first recrystallization was concentrated under reduced pressure, and then 1N Na
The solution was made basic with 50 mL of an aqueous OH solution and extracted with methylene chloride (4 × 200 mL). The organic layer was dried over sodium sulfate, and after removing the desiccant by filtration, the solvent was distilled off under reduced pressure and dried under vacuum. To this, 7.20 g (0.019 mol) of D-(-)-dibenzoyltartaric acid was added, and the mixture was recrystallized three times using a mixed solvent of water and ethanol to obtain optically pure (1R, 3R)-. Trans-3-amino-1-indanol-D-(-)-dibenzoyl tartrate (3.15 g) was obtained. The solution was made basic by adding 50 mL of a 1N aqueous NaOH solution, and extracted with methylene chloride (4 × 200 mL). After the organic layer was dried over sodium sulfate, the desiccant was filtered off, the solvent was distilled off under reduced pressure, and the residue was dried under vacuum. This is benzene-hexane (1: 1, 40 m
By recrystallization from (L), colorless crystals (1S, 3
S) -trans-3-amino-1-indanol (I-
1) 1.43 g was obtained (yield 38%, optical purity 99% e.
e. or more).

【0039】融点 113.5〜114℃ [α]=38.1(c=1.00、エタノール) 尚、光学純度はHPLCにより下記条件で決定した。 カラム:CROWNPAK CR(ダイセル化学工業
(株)製) 流速:0.5mL/min 検出波長:200nm 展開溶媒:pH2 HClO4水溶液 ピーク:前(1S,3S)−(I−1)、後(1R,3
R)−(I−1) 実施例2[シス−3−アミノ−1−インダノールの合
成] (1)(±)−シス−N−アセチル−3−アミノ−1−
インダノール(VII)の合成 実施例1の(3)で得た化合物(IV)8.0g(0.0
42mol)をTHF100mLに溶解し、−78℃に
冷却したのち、1.01M BH3/THF42mL
(0.042mol)を徐々に加え、一晩攪拌した。1
N塩酸水溶液を加え反応を停止したのち、塩化メチレン
で抽出した。有機層を硫酸ナトリウムで乾燥し、乾燥剤
を濾別後、溶媒を減圧留去し、真空乾燥することによ
り、(±)−N−アセチル−3−アミノ−1−インダノ
ール(シス体:トランス体=3:1の混合物)(VI)
6.54gを得た。さらにシリカゲルカラムクロマトグ
ラフィー(流出液、酢酸エチル)により精製し、白色結
晶3.33gを得た。続いてこれを酢酸エチル(90m
L)から2回再結晶し、標記化合物(±)−(VII)
1.45gを得た(2段階収率 18%)。
Melting point: 113.5 to 114 ° C. [α] = 38.1 (c = 1.00, ethanol) The optical purity was determined by HPLC under the following conditions. Column: CROWNPAK CR (manufactured by Daicel Chemical Industries, Ltd.) Flow rate: 0.5 mL / min Detection Wavelength: 200 nm Developing solvent: pH 2 HClO 4 aqueous peak: before (1S, 3S) - (I -1), after (1R, 3
R)-(I-1) Example 2 [Synthesis of cis-3-amino-1-indanol] (1) (±) -cis-N-acetyl-3-amino-1-amino
Synthesis of indanol (VII) 8.0 g (0.0%) of compound (IV) obtained in (3) of Example 1
42 mol) was dissolved in 100 mL of THF and cooled to −78 ° C., followed by 42 mL of 1.01 M BH 3 / THF.
(0.042 mol) was added slowly, and the mixture was stirred overnight. 1
The reaction was stopped by adding an aqueous solution of N hydrochloric acid, followed by extraction with methylene chloride. The organic layer was dried over sodium sulfate, the desiccant was filtered off, the solvent was distilled off under reduced pressure, and the residue was dried under vacuum to obtain (±) -N-acetyl-3-amino-1-indanol (cis-form: trans-form). = 3: 1 mixture) (VI)
6.54 g were obtained. Further purification was performed by silica gel column chromatography (eluate, ethyl acetate) to obtain 3.33 g of white crystals. Subsequently, this was added to ethyl acetate (90 m
L) and recrystallized twice from the title compound (±)-(VII)
1.45 g were obtained (two-step yield 18%).

【0040】融点 170〜172℃1 H−NMR(CDCl3) δ=1.80(dt,1H,J=5.7,8.
1), 2.01(s,3H), 2.57(d,1H,J=6.3), 2.92(ddd,1H,J=6.
6,7.5,13.8), 5.15(dd,1H,J=6.3,13.1), 5.30(dd,1H,J=
7.5,13,5), 7.32-7.46(m,4H) IR(KBr) 3400, 3300, 1640, 1550, 1280, 1060,
990, 780, 760 cm-1 (2)(±)−シス−3−アミノ−1−インダノール
(I−2)の合成 (1)で得た(±)−(VII)4.09g(0.021
mol)を、1N水酸化ナトリウム溶液−エタノール混
合溶媒(100mL:10mL)に加熱溶解させ、6日
間加熱還流した。室温まで冷却後、塩化メチレン(4×
200mL)で抽出した。有機層を硫化ナトリウムで乾
燥後、乾燥剤を濾別し、溶媒を減圧留去後、真空乾燥
し、標記化合物(±)−(I−2)2.41gを得た
(収率75%)。
Melting point 170-172 ° C. 1 H-NMR (CDCl 3 ) δ = 1.80 (dt, 1H, J = 5.7,8.
1), 2.01 (s, 3H), 2.57 (d, 1H, J = 6.3), 2.92 (ddd, 1H, J = 6.
6,7.5,13.8), 5.15 (dd, 1H, J = 6.3,13.1), 5.30 (dd, 1H, J =
7.5,13,5), 7.32-7.46 (m, 4H) IR (KBr) 3400, 3300, 1640, 1550, 1280, 1060,
990, 780, 760 cm -1 (2) Synthesis of (±) -cis-3-amino-1-indanol (I-2) 4.09 g of (±)-(VII) obtained in (1) (0. 021
mol) was dissolved in a 1N sodium hydroxide solution-ethanol mixed solvent (100 mL: 10 mL) with heating, and the mixture was heated under reflux for 6 days. After cooling to room temperature, methylene chloride (4 ×
200 mL). The organic layer was dried over sodium sulfide, the desiccant was filtered off, the solvent was distilled off under reduced pressure, and the residue was dried under vacuum to obtain 2.41 g of the title compound (±)-(I-2) (yield 75%). .

【0041】融点 67〜75℃1 H−NMR(CDCl3) δ=1.64(dt,1H,J=6.6,1.
2), 2.13(br s,3H), 2.81(dt,1H,J=6.6,13.2), 4.24(t,
1H,J=6.3), 5.05(t,1H,J=6.0), 7.302-7.443(m,4H) IR(KBr) 3350, 1580, 1460, 1340, 1050, 770,
740 cm-1 (3)(±)−シス−3−アミノ−1−インダノール
(I−2)の光学分割 (2)で得た化合物(±)−(I−2)を下記のHPL
C条件にて光学分割した。 カラム:CROWNPAK CR(+)(ダイセル化学
工業(株)製) 流速:1.0mL/min 検出波長:220nm 展開溶媒:pH1.9 HClO4水溶液 温度:10℃ HPLC分取された前成分−(I−2)と後成分−(I
−2)の各フラクションは、濃縮後10%苛性ソーダ水
溶液を加えて塩基性にした後、クロロホルムで抽出する
ことにより目的の光学活性前成分−(I−2)(収率2
8%、光学純度97.3%e.e)と光学活性後成分−
(I−2)(収率18%、光学純度95%e.e)を得
た。尚、光学純度は実施例1と同様の条件で決定した。
Melting point 67-75 ° C. 1 H-NMR (CDCl 3 ) δ = 1.64 (dt, 1H, J = 6.6, 1.
2), 2.13 (br s, 3H), 2.81 (dt, 1H, J = 6.6,13.2), 4.24 (t,
1H, J = 6.3), 5.05 (t, 1H, J = 6.0), 7.302-7.443 (m, 4H) IR (KBr) 3350, 1580, 1460, 1340, 1050, 770,
740 cm -1 (3) Optical resolution of (±) -cis-3-amino-1-indanol (I-2) The compound (±)-(I-2) obtained in (2) was converted to the following HPL
Optical division was performed under the condition C. Column: CROWNPAK CR (+) (manufactured by Daicel Chemical Industries, Ltd.) Flow rate: 1.0 mL / min Detection wavelength: 220 nm Developing solvent: pH 1.9 HClO 4 aqueous solution Temperature: 10 ° C. -2) and the subsequent component-(I
After concentration, each fraction is made basic by adding a 10% aqueous solution of caustic soda, and then extracted with chloroform to obtain the desired optically active component- (I-2) (yield 2).
8%, optical purity 97.3% ee) and the component after optical activity-
(I-2) (18% yield, optical purity 95% ee) was obtained. The optical purity was determined under the same conditions as in Example 1.

【0042】光学活性前成分−(I−2)のIR、1
−NMR及びCDの測定結果を以下に示す。また光学活
性前成分−(I−2)のCDスペクトルを図1に示す。
Optically active component-IR of the component (I-2), 1 H
-The measurement results of NMR and CD are shown below. FIG. 1 shows the CD spectrum of the optically active component- (I-2).

【0043】IR(neat) 3350, 1645, 1580, 1455, 1
325, 1090, 1045, 760, 735cm-1 1 H−NMR(300MHz)(CDCl3) δ=1.63(ddd,1
H,J=6.6,6.6,6.6Hz),2.43(bs,3H+H2O), 2.73(ddd,1H,J=
6.6,6.6,6.6Hz), 4.21(dd,1H,J=6.6,6.6Hz),5.02(dd,1
H,J=6.6,6.6Hz), 7.2-7.5(m,4H) ppm CD(CHCl3、5.4×10-4M)−5.6mdeg(285nm),
−5.0mdeg(296nm) 応用例 実施例1の(6)で得られた、(1S、3S)−トラン
ス−3−アミノ−1−インダノール、比較のために、表
1に示す(1S、2S)−トランス−1−アミノ−2−
インダノール及び(1S、2S)−トランス−2−アミ
ノ−1−インダノールを分離剤として用い、ジアステレ
オマー晶析法で、表1に示す分離対象化合物1及び2の
ラセミ体の光学分割を行った。
IR (neat) 3350, 1645, 1580, 1455, 1
325, 1090, 1045, 760, 735cm -1 1 H-NMR (300MHz) (CDCl 3) δ = 1.63 (ddd, 1
H, J = 6.6,6.6,6.6Hz), 2.43 (bs, 3H + H 2 O), 2.73 (ddd, 1H, J =
6.6,6.6,6.6Hz), 4.21 (dd, 1H, J = 6.6,6.6Hz), 5.02 (dd, 1
H, J = 6.6,6.6Hz), 7.2-7.5 (m, 4H) ppm CD (CHCl 3 , 5.4 × 10 -4 M) -5.6mdeg (285nm),
-5.0 mdeg (296 nm) Application example (1S, 3S) -trans-3-amino-1-indanol obtained in (6) of Example 1, and shown in Table 1 for comparison (1S, 2S) -Trans-1-amino-2-
Using indanol and (1S, 2S) -trans-2-amino-1-indanol as separating agents, the racemates of compounds 1 and 2 shown in Table 1 were optically resolved by diastereomeric crystallization. .

【0044】即ち、本発明の分離剤の場合は、分離剤と
分離対象化合物のラセミ体とを、当モル量ずつ、アセト
ニトリルに溶解させ、4℃に冷却して結晶を析出させ
た。また、比較の分離剤の場合は、分離剤と分離対象化
合物のラセミ体とを、当モル量ずつ、水−エタノール混
合溶媒(1:1)に加熱溶解させ、26℃で放置して結
晶を析出させた。結果を表1に示す。
That is, in the case of the separating agent of the present invention, equimolar amounts of the separating agent and the racemate of the compound to be separated were dissolved in acetonitrile and cooled to 4 ° C. to precipitate crystals. In the case of the comparative separating agent, an equimolar amount of the separating agent and the racemate of the compound to be separated are dissolved by heating in a mixed solvent of water and ethanol (1: 1) and left at 26 ° C. to form crystals. Was deposited. Table 1 shows the results.

【0045】[0045]

【表1】 [Table 1]

【0046】表1の結果より、本発明の分離剤は、比較
の分離剤に比べ、分離対象化合物のラセミ体を効率よく
分離できることがわかる。
From the results shown in Table 1, it can be seen that the separating agent of the present invention can separate the racemate of the compound to be separated more efficiently than the comparative separating agent.

【0047】[0047]

【発明の効果】本発明の新規な3−アミノ−1−インダ
ノールは、医・農薬、とりわけ医薬の合成中間体として
極めて重要な化合物である。更に光学活性な3−アミノ
−1−インダノールは、光学活性カルボン酸の分離剤と
しても幅広く利用することができる。
Industrial Applicability The novel 3-amino-1-indanol of the present invention is a very important compound as an intermediate for the synthesis of medical and agricultural chemicals, especially pharmaceuticals. Further, optically active 3-amino-1-indanol can be widely used as a separating agent for optically active carboxylic acids.

【図面の簡単な説明】[Brief description of the drawings]

【図1】 実施例2の(3)で得られた光学活性前成分
−(I−2)のCDスペクトルである。
FIG. 1 is a CD spectrum of an optically active component- (I-2) obtained in (3) of Example 2.

───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.7 識別記号 FI テーマコート゛(参考) C07C 225/20 C07C 225/20 227/10 227/10 229/34 229/34 // C07M 7:00 C07M 7:00 ──────────────────────────────────────────────────続 き Continued on the front page (51) Int.Cl. 7 Identification symbol FI theme coat ゛ (Reference) C07C 225/20 C07C 225/20 227/10 227/10 229/34 229/34 // C07M 7:00 C07M 7:00

Claims (5)

【特許請求の範囲】[Claims] 【請求項1】 式(I)で表される3−アミノ−1−イ
ンダノール。 【化1】 (式中、OH基とNH2基はシス配置またはトランス配
置であり、ラセミ体でも光学活性体でもよい。)
1. A 3-amino-1-indanol represented by the formula (I). Embedded image (In the formula, the OH group and the NH 2 group have a cis configuration or a trans configuration, and may be a racemic form or an optically active form.)
【請求項2】 式(II) 【化2】 で表されるβ−フェニル−β−アラニンのアミノ基を保
護基で保護して、式(III) 【化3】 [式中、AはRCO−又はROCO−基を示す。ここで
Rは炭素数1〜30のアルキル基又はアリール基であ
る。]で表される化合物を得、この化合物をFriedel-Cr
aftsアシル化することにより式(IV) 【化4】 (式中、Aは前記と同じ意味を示す。)で表される化合
物を得、更にこの化合物の保護基の除去及び還元を行う
ことを特徴とする請求項1記載の3−アミノ−1−イン
ダノールの合成方法。
2. A compound of the formula (II) The amino group of β-phenyl-β-alanine represented by the formula (III) is protected by a protecting group. [In the formula, A represents an RCO- or ROCO- group. Here, R is an alkyl group or an aryl group having 1 to 30 carbon atoms. To obtain a compound represented by the formula: Friedel-Cr
Formula (IV) by afts acylation (Wherein A has the same meaning as described above), and the protecting group of the compound is further removed and reduced. A method for synthesizing indanol.
【請求項3】 光学活性体である請求項1記載の3−ア
ミノ−1−インダノール。
3. The 3-amino-1-indanol according to claim 1, which is an optically active substance.
【請求項4】 請求項1記載の3−アミノ−1−インダ
ノールの光学活性体混合物を光学活性カルボン酸と作用
させた後、生成するジアステレオマー塩を分離すること
を特徴とする3−アミノ−1−インダノールの光学分割
方法。
4. The method of claim 3, wherein the mixture of the optically active substance of 3-amino-1-indanol according to claim 1 is reacted with an optically active carboxylic acid, and the resulting diastereomeric salt is separated. -1- Optical resolution method of indanol.
【請求項5】 請求項1記載の3−アミノ−1−インダ
ノールの光学活性体を有効成分とする光学異性体用分離
剤。
5. A separating agent for optical isomers comprising the optically active 3-amino-1-indanol according to claim 1 as an active ingredient.
JP2001268690A 2000-09-06 2001-09-05 3-amino-1-indanol, method for synthesizing the same and optical isomer separating agent comprising the same Pending JP2002155035A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2001268690A JP2002155035A (en) 2000-09-06 2001-09-05 3-amino-1-indanol, method for synthesizing the same and optical isomer separating agent comprising the same

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2000270036 2000-09-06
JP2000-270036 2000-09-06
JP2001268690A JP2002155035A (en) 2000-09-06 2001-09-05 3-amino-1-indanol, method for synthesizing the same and optical isomer separating agent comprising the same

Publications (1)

Publication Number Publication Date
JP2002155035A true JP2002155035A (en) 2002-05-28

Family

ID=26599341

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001268690A Pending JP2002155035A (en) 2000-09-06 2001-09-05 3-amino-1-indanol, method for synthesizing the same and optical isomer separating agent comprising the same

Country Status (1)

Country Link
JP (1) JP2002155035A (en)

Similar Documents

Publication Publication Date Title
US5545745A (en) Enantioselective preparation of optically pure albuterol
JP2014074033A (en) Methods for isolating propargylated aminoindanes
WO2008062460A2 (en) Crystalline forms of pregabalin
KR20050113292A (en) Process for the preparation of optically pure 4-hydroxy-2-oxo-1-pyrrolidineacetamide
JPH0623150B2 (en) Process for producing optically active 3-hydroxybutanoic acids
JP2005247828A (en) Method for producing optically active serine derivative
JPH04187674A (en) Production of (-)-1-benzyl-4-((5,6-dimethoxy-1-indanon)-2-yl)methylpiperidine
US6479702B1 (en) 3-amino-1-indanole, method of synthesizing the same and method of optical resolution
HU227114B1 (en) (1r, 2s, 4r)-(-)-2-[n,n-(dimethylamino-ethoxy)]-2-phenyl-1,7,7-trimethyl-bicyclo[2.2.1]heptane of high purity and pharmaceutically acceptable acid addition salts thereof, process for preparation of them and medicaments containing the same
JPH02256655A (en) Production of optically active threo-dihydroxyphenylserine derivative
JP2002155035A (en) 3-amino-1-indanol, method for synthesizing the same and optical isomer separating agent comprising the same
WO2003051852A1 (en) Intermediate and process for producing optically active compound from the intermediate
JPH09208558A (en) Production of optically active 4-hydroxy-2-pyrrolidone
JPH04308550A (en) Method of stereoselectively converting diol into alcohol
JP4126921B2 (en) Process for producing optically active β-phenylalanine derivative
JP4104319B2 (en) Process for producing optically active 2-hydroxy-3-nitropropionic acid
JP3663643B2 (en) Process for producing optically active 1- (2,4-dichlorophenyl) ethylamine
HU205594B (en) Process for producing optical isomeres of cyclopropane-carboxylic acids5
JP2825608B2 (en) Optically active threo-3-amino-2-hydroxypentanoic acid and process for producing the same
JP2002371060A (en) Method for producing optically active aminopiperidine derivative
JP4380325B2 (en) Process for producing optically active carboxylic acid
JP2008143786A (en) Optical resolution method
JP2000239237A (en) Crystal of optically active compound and its production
JP3738470B2 (en) Process for producing optically active 1- (dichloro-substituted phenyl) ethylamines
JP4335390B2 (en) Method for producing optically active oxazolidinone derivative